Invetx: Invetx's $60.5 Million Series B Financing
Latham & Watkins advised Invetx on the deal. Invetx, a pioneer in protein-based therapeutics for animal health, has announced that it has raised US$60.5 million in [...]
Read full article »
Invetx is a Massachusetts-based biopharmaceutical company that researches and develops veterinary monoclonal antibodies for animal health conditions.
Read more